Screener
MiMedx Group MDXG Reportable Segment — G&A
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by MiMedx Group in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: MiMedx Group’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001376339-26-000071
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Selling and marketing | $46,416 | $47,867 | $90,328 | $94,728 |
| General and administrative | 13,363 | 16,284 | 22,682 | 29,392 |
| Selling, general and administrative | $59,779 | $64,151 | $113,010 | $124,120 |
Item 1. Financial Statements
FAQ
- What is MiMedx Group's reportable segment — G&A?
- MiMedx Group (MDXG) reported reportable segment — G&A of $13.36M in Q2 2026.
- What does reportable segment — G&A mean?
- This metric reflects the overhead costs incurred to manage and support the operations of a specific reportable business segment. It includes expenses for executive management, legal, human resources, finance, and other corporate functions not directly tied to production or sales. Tracking these costs is essential for assessing the operational leverage and administrative scalability of the business unit.
Ask your AI about MiMedx Group's reportable segment — g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude